Pharmacogenetics of inflammatory bowel disease

Novartis Foundation Symposium

Volumn 263, Issue , 2004, Pages 41-53

  Kelleher, Dermot ^a   Farrell, Richard ^b   McManus, Ross ^a  

^a Dublin Molecular Medicine Centre   (Ireland)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; GASTROINTESTINAL AGENT; GLUCOCORTICOID RECEPTOR; GLYCOPROTEIN P; INFLIXIMAB; METHYLTRANSFERASE; MONOCLONAL ANTIBODY; STEROID; THIOPURINE METHYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

BIOLOGICAL MODEL; ENTERITIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; HUMAN; INFLAMMATION; METABOLISM; METHODOLOGY; PHARMACOGENETICS; REVIEW;

ANTIBODIES, MONOCLONAL; AZATHIOPRINE; GASTROINTESTINAL AGENTS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; METHYLTRANSFERASES; MODELS, BIOLOGICAL; P-GLYCOPROTEIN; PHARMACOGENETICS; POLYMORPHISM, GENETIC; RECEPTORS, GLUCOCORTICOID; STEROIDS; TUMOR NECROSIS FACTOR-ALPHA; VARIATION (GENETICS);

EID: 13844320542     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (30)

1. Ameyaw MM, Regateiro F, Li T et al 2001 MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 11: 217-221
2. Brant SR, Panhuysen CIM, Nicolae D et al 2003 MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73:1282-1292
3. Cascorbi I, Gerloff T, Johne A 2001 Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 69:169-174
4. Colombel JF, Ferrari N, Debuysere H 2000 Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 118:1025-1030
5. Croucher PJ, Mascheretti S, Foelsch UR et al 2003 Lack of association between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations. Gastroenterology 125:1919-1920
6. Deroo BJ, Archer TK 2001 Glucocorticoid receptor activation of the I kappa B alpha promoter within chromatin. Mol Biol Cell 12:3365-3374
7. Fairchild CR, Moscow JA, O'Brien EE, Cowan KH 1990 Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi. Mol Pharmacol 37:801-809
8. Farrell RJ, Murphy A, Long A et al 2000 High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 118:279-288
9. Fellay J, Marzolini C, Meaden ER et al 2002 Swiss HIV Cohort Study. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 359:30-36
10. Fromm MF 2002 The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans. Adv Drug Deliv Rev 54:1295-1310
11. Hearing SD, Norman M, Probert CS, Haslam N, Dayan CM 1999 Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 45:382-388
12. Hitzl M, Drescher S, van der Kuip H et al 2001 The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 11:293-298
13. Ho GT, Moodie FM, Satsangi J 2003 Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? Gut 52:759-766
14. Hoffmeyer S, Burk O, von Richter O et al 2000 Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97:3473-3478
15. Honda M, Orii F, Ayabe T et al 2000 Expression of glucocorticoid receptor in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118:859-866
16. Kim RB, Leake BF, Choo EF et al 2001 Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 70:189-199
17. Kimchi-Sarfaty C, Gribar JJ, Gottesman MM 2002 Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. Mol Pharmacol 62:1-6
18. Mickley LA, Lee JS, Weng Z et al 1998 Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood 91:1749-1956
19. Mugnier B, Balandraud N, Darque A, Roudier C, Roudier J, Reviron D 2003 Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis. Arthritis Rheum 48:1849-1852
20. Nakamura T, Sakaeda T, Horinouchi M et al 2002 Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther 71:297-303
21. Ogura Y, Bonen DK, Inohara N et al 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-606
22. Sakaeda T, Nakamura T, Horinouchi M et al 2001 MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm Res 18:1400-1404
23. Sakaeda T, Nakamura T, Okumura K 2002 MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biol Pharm Bull 25:1391-1400
24. Schaeffeler E, Eichelbaum M, Brinkmann U et al 2001 Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet 358:383-384
25. Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P 1995 Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 1995:1698-1705
26. Schwab M, Schaeffeler E, Marx C et al 2003a Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124:26-33
27. Schwab M, Eichelbaum M, Fromm MF 2003b Genetic polymorphisms of the human MDR1 drug transporter. Annu Rev Pharmacol Toxicol 43:285-307
28. Tanabe M, Ieiri I, Nagata N et al 2001 Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 297:1137-1143
29. Taylor KD, Plevy SE, Yang H et al 2001 ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease. Gastroenterology 120:1347-1355
30. Weinshilboum R 2001 Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab Dispos 29:601-605